Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Iontas
Iontas
Activities:
Ingredients
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
The (r)evolution of biocatalysis in API synthesis
Explore Farmhispania Group’s enzyme toolbox to develop cost-effective, green-by-design synthetic routes for the cGMP production of your small-molecule NCEs
From batch to continuous chemistry to continuous processing
The main challenge in many flow reactors lies in achieving a smooth and continuous flow within microchannels. Dec Group focuses on effectively transporting solid materials and...
PCI Pharma Services commences installation of sterile fill-finish and lyophilisation line
The Bedford, NH site will advance PCI's manufacturing capabilities with twin lyophilisers and a large-scale isolator filling line, making this the third sterile fill-finish...
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Research & Development
IONTAS identifies SARS-CoV-2 variant neutralising antibodies
The company is now seeking development partners to progress the antibodies
Pharmaceutical
IONTAS celebrates 5 years of antibody discovery
The occasion marks a milestone for the company that provides discovery services and bespoke phage display libraries to the biotechnology and pharmaceutical industries
Pharmaceutical
IONTAS signs collaboration agreement with LG Chem
Under the agreement IONTAS will use its proprietary antibody discovery platforms to deliver antibodies against biological targets selected by LG Chem
Ingredients
Collaboration to identify antibodies for cancer targets
Iontas and IGEM Therapeutics will work together to develop novel immunoglobulin E antibodoes
Ingredients
Iontas to generate antibodies using mammalian display technology
Iontas to generate antibodies with favourable, binding and expression properties using its mammalian display antibody discovery platform
Subscribe now